- Conditions
- Respiratory Failure, ARDS
- Interventions
- Marker Therapeutics D2000 Cartridge (D2000) for use with the Spectra Optia® Apheresis System (Optia SPD Protocol)
- Device
- Lead sponsor
- Marker Therapeutics AG
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 107 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2022
- U.S. locations
- 7
- States / cities
- Little Rock, Arkansas • Albuquerque, New Mexico • Portland, Oregon + 4 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 241–264
of 1,071
matching trials from the live ClinicalTrials.gov search.
- Conditions
- SARS-CoV-2
- Interventions
- mRNA-1273 Variant-containing Formulation
- Biological
- Lead sponsor
- ModernaTX, Inc.
- Industry
- Eligibility
- 6 Months and older
- Enrollment
- 1,144 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2024 – 2026
- U.S. locations
- 6
- States / cities
- Atlanta, Georgia • Decatur, Georgia • Baton Rouge, Louisiana + 3 more
- Conditions
- Parenting, Covid19
- Interventions
- CARE Program and Valera Application with care manager functionality, Valera Application with care manager functionality, CARE Program, Valera Application, CARE Program and Valera Application
- Behavioral
- Lead sponsor
- Albert Einstein College of Medicine
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 367 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2026
- U.S. locations
- 1
- States / cities
- The Bronx, New York
- Conditions
- Severe COVID-19 Disease
- Interventions
- RAPA-501-Allo off-the-shelf Therapy of COVID-19, Placebo
- Biological · Other
- Lead sponsor
- Rapa Therapeutics LLC
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 1 participant
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2021
- U.S. locations
- 1
- States / cities
- Hackensack, New Jersey
- Conditions
- Covid19, SARS-CoV Infection
- Interventions
- Fisetin, Placebo
- Drug
- Lead sponsor
- Mayo Clinic
- Other
- Eligibility
- 65 Years and older
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2024
- U.S. locations
- 1
- States / cities
- Rochester, Minnesota
- Conditions
- Covid19
- Interventions
- COVID-19 Testing Home-based (Aim 1), COVID-19 Testing Mobile (Aim 1), COVID-19 Testing Mobile Approach 1 (Aim 2), COVID-19 Testing Mobile Approach 2 (Aim 2)
- Other
- Lead sponsor
- San Diego State University
- Other
- Eligibility
- 6 Years to 120 Years
- Enrollment
- 32,750 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2020 – 2023
- U.S. locations
- 1
- States / cities
- San Diego, California
- Conditions
- COVID-19
- Interventions
- RT-PCR Test, Real-time PCR Test
- Diagnostic Test
- Lead sponsor
- QuantuMDx Group Ltd
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 877 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2023
- U.S. locations
- 3
- States / cities
- Miami, Florida • Knoxville, Tennessee • Memphis, Tennessee
- Conditions
- COVID-19, Influenza A, Influenza Type B, RSV Infection
- Interventions
- LumiraDx SARS-CoV-2 & Flu A/B test, LumiraDx SARS-CoV-2 & RSV test
- Diagnostic Test
- Lead sponsor
- LumiraDx UK Limited
- Industry
- Eligibility
- Not listed
- Enrollment
- 589 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2023
- U.S. locations
- 8
- States / cities
- Cullman, Alabama • Encinitas, California • Miami, Florida + 5 more
- Conditions
- Long COVID
- Interventions
- Acupuncture
- Procedure
- Lead sponsor
- Southern California University of Health Sciences
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 10 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2026
- U.S. locations
- 1
- States / cities
- Whittier, California
- Conditions
- SARS-CoV-2 Infection, COVID-19, SARS-CoV-2 Acute Respiratory Disease, SARS (Disease)
- Interventions
- BNT162b2, Multivalent BNT162b2 (B.1.1.7 + B.1.617.2), Monovalent BNT162b2 (B.1.1.7), Monovalent BNT162b2 (B.1.617.2), Monovalent BNT162b2 (B.1.1.529.1), Observational
- Biological · Other
- Lead sponsor
- BioNTech SE
- Industry
- Eligibility
- 18 Years to 85 Years
- Enrollment
- 1,380 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2021 – 2023
- U.S. locations
- 14
- States / cities
- Long Beach, California • San Diego, California • Milford, Connecticut + 10 more
- Conditions
- Healthy Participants
- Interventions
- Combination [RSVpreF+BNTb162b2], Bivalent BNT162b2 (original/Omi BA.4/BA.5), RSVpreF, QIV, Normal Saline Placebo
- Biological
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 65 Years and older
- Enrollment
- 1,142 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2023 – 2024
- U.S. locations
- 37
- States / cities
- Dublin, California • Huntington Beach, California • Lake Forest, California + 26 more
- Conditions
- COVID-19
- Interventions
- Not listed
- Lead sponsor
- National Institute of Dental and Craniofacial Research (NIDCR)
- NIH
- Eligibility
- 18 Years and older
- Enrollment
- 55 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2022
- U.S. locations
- 1
- States / cities
- Bethesda, Maryland
- Conditions
- COVID-19
- Interventions
- HB-adMSC, Placebo
- Biological · Other
- Lead sponsor
- Hope Biosciences Research Foundation
- Industry
- Eligibility
- Not listed
- Enrollment
- 48 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2021
- U.S. locations
- 2
- States / cities
- Houston, Texas
- Conditions
- Covid19, Coronavirus, Coronavirus Infection, Corona Virus Infection
- Interventions
- Ebselen, Placebo
- Drug
- Lead sponsor
- Sound Pharmaceuticals, Incorporated
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 25 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2023
- U.S. locations
- 7
- States / cities
- New Haven, Connecticut • Boise, Idaho • Kansas City, Kansas + 4 more
- Conditions
- Fatigue, Dyspnea, Cognitive Impairment, Muscle Pain
- Interventions
- the multi-domain Tai Chi Digital therapy Software Application
- Device
- Lead sponsor
- Tim Shi
- Other
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 200 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2022 – 2023
- U.S. locations
- 1
- States / cities
- Ellicott City, Maryland
- Conditions
- Covid19
- Interventions
- Dexamethasone
- Drug
- Lead sponsor
- University of Oklahoma
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 110 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2022
- U.S. locations
- 1
- States / cities
- Oklahoma City, Oklahoma
- Conditions
- COVID -19
- Interventions
- RVX-sCPD9
- Biological
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 18 Years to 64 Years
- Enrollment
- 80 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026 – 2027
- U.S. locations
- 4
- States / cities
- New York, New York • Durham, North Carolina • Cincinnati, Ohio + 1 more
- Conditions
- Influenza a, Influenza B, RSV, COVID 19
- Interventions
- LIAISON NES FLU A/B, RSV & COVID-19
- Diagnostic Test
- Lead sponsor
- DiaSorin Molecular LLC
- Industry
- Eligibility
- Not listed
- Enrollment
- 1,000 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2025
- U.S. locations
- 3
- States / cities
- Henderson, Nevada • Pittsburgh, Pennsylvania • McAllen, Texas
- Conditions
- Invasive Fungal Infections
- Interventions
- fosmanogepix
- Drug
- Lead sponsor
- Basilea Pharmaceutica
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 21 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2022
- U.S. locations
- 6
- States / cities
- Duarte, California • Durham, North Carolina
- Conditions
- COVID-19
- Interventions
- Behavioral questionaires
- Behavioral
- Lead sponsor
- Duke University
- Other
- Eligibility
- 12 Years and older
- Enrollment
- 2,778 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2021 – 2022
- U.S. locations
- 1
- States / cities
- Merced, California
- Conditions
- SARS-CoV2 Infection
- Interventions
- Rapid Antigen Screening Test
- Device
- Lead sponsor
- Columbia University
- Other
- Eligibility
- 2 Years and older
- Enrollment
- 337 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2021 – 2022
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Children With Medical Complexity (CMC), COVID-19
- Interventions
- BinaxNOW Rapid Antigen System
- Diagnostic Test
- Lead sponsor
- University of Wisconsin, Madison
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 112 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2021 – 2023
- U.S. locations
- 1
- States / cities
- Madison, Wisconsin
- Conditions
- Covid19
- Interventions
- Sotrovimab (Gen1), Sotrovimab (Gen2)
- Biological
- Lead sponsor
- Vir Biotechnology, Inc.
- Industry
- Eligibility
- 18 Years to 69 Years
- Enrollment
- 354 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2022
- U.S. locations
- 18
- States / cities
- Anniston, Alabama • Bakersfield, California • Northridge, California + 12 more
- Conditions
- Severe Acute Respiratory Syndrome Coronavirus 2, Aspergillosis Invasive
- Interventions
- Isavuconazonium Injection [Cresemba], Placebo
- Drug
- Lead sponsor
- Jeffrey Jenks, MD, MPH
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 8 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021
- U.S. locations
- 3
- States / cities
- Orange, California • Sacramento, California • San Diego, California